Authors: Gamache, DA Graff, G Brady, MT Spellman, JM Yanni, JM

Citation: Da. Gamache et al., Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy, INFLAMMATIO, 24(4), 2000, pp. 357-370

Authors: Ke, TL Graff, G Spellman, JM Yanni, JM

Citation: Tl. Ke et al., Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers, INFLAMMATIO, 24(4), 2000, pp. 371-384

Authors: Yanni, JM Sharif, NA Gamache, DA Miller, ST Weimer, LK Spellman, JM

Citation: Jm. Yanni et al., A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: Effects of new topical ocular drugs, ACT OPHTH S, 77, 1999, pp. 33-37

Authors: Yanni, JM Weimer, LK Sharif, NA Xu, SX Gamache, DA Spellman, JM

Citation: Jm. Yanni et al., Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs, ARCH OPHTH, 117(5), 1999, pp. 643-647

Authors: Bhattacherjee, P Paterson, CA Spellman, JM Graff, G Yanni, JM

Citation: P. Bhattacherjee et al., Pharmacological validation of a feline model of steroid-induced ocular hypertension, ARCH OPHTH, 117(3), 1999, pp. 361-364

Authors: Graff, G Brady, MT Gamache, DA Spellman, JM Yanni, JM

Citation: G. Graff et al., Transient loss of prostaglandin synthetic capacity in rabbit iris-ciliary body following anterior chamber paracentesis, OCUL IMMU I, 6(4), 1998, pp. 227-238